The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Hepatic Accumulation of Hypoxanthine: A Link Between Hyperuricemia and Nonalcoholic Fatty Liver Disease
Open accessAbstract
An elevated level of plasma uric acid has been widely recognized as a risk factor for non-alcoholic fatty liver disease (NAFLD), where oxidative stress and inflammation play an important role in the pathophysiology of the disease. Although the complete molecular mechanisms involved remain unknown, while under physiological conditions uric acid presents antioxidant properties, hyperuricemia has been linked to oxidative stress, chronic low-grade inflammation, and insulin resistance, basic signs of NAFLD. Employing in vivo experimentation, we aim to investigate whether a high-fat diet rich in cholesterol (HFD), modifies the metabolism of purines in close relationship to molecular events associated with the development of NAFLD. In vitro experiments employing HepG2 cells are also carried out to study the phenomenon of oxidative stress. Adult male rabbits were fed for 8 weeks an HFD to induce NAFLD. At the beginning of the experiment and every 15 d until the completion of the study, plasma levels of lipids, lipoproteins, and uric acid were measured. Liver tissue was isolated, and histology performed followed by the biochemical determination of hypoxanthine, protein expression of xanthine oxidoreductase (XOR) by western blot analysis, and xanthine oxidase (XO) activity using an enzymatic kinetic assay. Furthermore, we employed in vitro experimentation studying HepG2 cells to measure the effect of hypoxanthine and H2O2 upon the production of radical oxygen species (ROS), XO activity, and cell viability. Hepatic tissue from rabbits fed the HFD diet showed signs of NAFLD associated with an increased ROS concentration and an altered purine metabolism characterized by the increase in hypoxanthine, together with an apparent equilibrium displacement of XOR towards the xanthine dehydrogenase (XDH) isoform of the enzyme. This protein shift visualized by a western blot analysis, associated with an increase in plasma uric acid and hepatocyte hypoxanthine could be understood as a compensatory series of events secondary to the establishment of oxidative stress associated with the chronic establishment of fatty liver disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Detected differences in metabolites between the HRX215- and vehicle-treated group were related to carnitines and hypoxanthines, offering a mechanistic explanation for the observed antisteatotic effects35,36 (Figures S3A–S3C).”
From First-in-class MKK4 inhibitors enhance liver regeneration and prevent liver failure (2024) · cites this paper as [35]
Citations
Cites
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Buzzetti, E., Pinzani, M., & Tsochatzis, E. A. (2016) · Metabolism · doi:10.1016/j.metabol.2015.12.012 · Cited by 3,119
Serum Uric Acid and Cardiovascular Mortality: The NHANES I Epidemiologic Follow-up Study, 1971-1992
Fang, J., & Alderman, M. H. (2000) · JAMA · doi:10.1001/jama.283.18.2404 · Cited by 1,513
Guerin, P. (2001) · Human Reproduction Update · doi:10.1093/humupd/7.2.175 · Cited by 1,418
Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study
Culleton, B. F., Larson, M. G., Kannel, W. B., & Levy, D. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-1-199907060-00003 · Cited by 1,282
Taylor, R. S., Taylor, R. J., Bayliss, S., Hagström, H., Nasr, P., Schattenberg, J. M., Ishigami, M., Toyoda, H., Wai-Sun Wong, V., Peleg, N., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.043 · Cited by 1,069
Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease
Masarone, M., Rosato, V., Dallio, M., Gravina, A. G., Aglitti, A., Loguercio, C., Federico, A., & Persico, M. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/9547613 · Cited by 648
Methionine in proteins defends against oxidative stress
Luo, S., & Levine, R. L. (2009) · The FASEB Journal · doi:10.1096/fj.08-118414 · Cited by 461
Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups
Lonardo, A., Bellentani, S., Argo, C. K., Ballestri, S., Byrne, C. D., Caldwell, S. H., Cortez-Pinto, H., Grieco, A., Machado, M. V., Miele, L., et al. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.08.004 · Cited by 444
Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Brown, G. T., & Kleiner, D. E. (2016) · Metabolism · doi:10.1016/j.metabol.2015.11.008 · Cited by 363
Non‐alcoholic steatohepatitis in type 2 diabetes mellitus
GUPTE, P., AMARAPURKAR, D., AGAL, S., BAIJAL, R., KULSHRESTHA, P., PRAMANIK, S., PATEL, N., MADAN, A., AMARAPURKAR, A., & HAFEEZUNNISA (2004) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2004.03312.x · Cited by 329
Lactate dehydrogenase activity as an effect criterion in toxicity tests with Daphnia magna straus
Diamantino, T. C., Almeida, E., Soares, A. M. V. M., & Guilhermino, L. (2001) · Chemosphere · doi:10.1016/s0045-6535(01)00029-7 · Cited by 306
Choi, Y.-J., Shin, H.-S., Choi, H. S., Park, J.-W., Jo, I., Oh, E.-S., Lee, K.-Y., Lee, B.-H., Johnson, R. J., & Kang, D.-H. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.98 · Cited by 283
Involvement of free radicals and oxidative stress in NAFLD/NASH
Sumida, Y., Niki, E., Naito, Y., & Yoshikawa, T. (2013) · Free Radical Research · doi:10.3109/10715762.2013.837577 · Cited by 280
The paradoxical relationship between serum uric acid and cardiovascular disease
Lippi, G., Montagnana, M., Franchini, M., Favaloro, E. J., & Targher, G. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.02.024 · Cited by 248
Alía, M., Ramos, S., Mateos, R., Bravo, L., & Goya, L. (2005) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.20061 · Cited by 236
The role of xanthine oxidoreductase and uric acid in metabolic syndrome
Battelli, M. G., Bortolotti, M., Polito, L., & Bolognesi, A. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.05.003 · Cited by 216
Kushiyama, A., Nakatsu, Y., Matsunaga, Y., Yamamotoya, T., Mori, K., Ueda, K., Inoue, Y., Sakoda, H., Fujishiro, M., Ono, H., et al. (2016) · Mediators of Inflammation · doi:10.1155/2016/8603164 · Cited by 189
Recent advances on uric acid transporters
Xu, L., Shi, Y., Zhuang, S., & Liu, N. (2017) · Oncotarget · doi:10.18632/oncotarget.20135 · Cited by 180
Regulation of Xanthine Oxidoreductase Protein Expression by Hydrogen Peroxide and Calcium
McNally, J. S., Saxena, A., Cai, H. “., Dikalov, S., & Harrison, D. G. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000170827.16296.6e · Cited by 115
Bush, K. T., Wu, W., Lun, C., & Nigám, S. K. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.796516 · Cited by 115
Wang, R., Song, Y., Yan, Y., & Ding, Z. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.10.006 · Cited by 108
Zhou, Y., Wei, F., & Fan, Y. (2015) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2015.12.010 · Cited by 100
HYPERURICEMIA—RELATIONSHIP TO HYPERCHOLESTEREMIA AND ACUTE MYOCARDIAL INFARCTION
Kohn, P. M. (1959) · JAMA · doi:10.1001/jama.1959.03010160025007 · Cited by 94
Renaud, H. J., Cui, J. Y., Lü, H., & Klaassen, C. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088584 · Cited by 88
Morelli, A., Comeglio, P., Filippi, S., Sarchielli, E., Vignozzi, L., Maneschi, E., Cellai, I., Gacci, M., Lenzi, A., Vannelli, G. B., et al. (2012) · The Prostate · doi:10.1002/pros.22584 · Cited by 87
Xanthine Oxidase Inhibition Attenuates Insulin Resistance and Diet-Induced Steatohepatitis in Mice
Nishikawa, T., Nagata, N., Shimakami, T., Shirakura, T., Matsui, C., Ni, Y., Zhuge, F., Xu, L., Chen, G., Nagashimada, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-020-57784-3 · Cited by 85
Xanthine oxidoreductase activity in human liver disease
Stirpe, F., Ravaioli, M., Battelli, M. G., Musiani, S., & Grazi, G. L. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05925.x · Cited by 74
Madsen, T. E., Muhlestein, J. B., Carlquist, J. F., Horne, B. D., Bair, T. L., Jackson, J. D., Lappé, J. M., Pearson, R. R., & Anderson, J. L. (2005) · American Journal of Nephrology · doi:10.1159/000084085 · Cited by 68
Lopez, D. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.01.003 · Cited by 64
Selvi, N. M. K. (2015) · Scientia Pharmaceutica · doi:10.3797/scipharm.1408-16 · Cited by 59
Lebeau, P. F., Al‐Hashimi, A., Sood, S. K., Lhoták, Š., Yu, P., Gyulay, G., Paré, G., Chen, S. R. W., Trigatti, B. L., Prat, A., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.744235 · Cited by 52
Black, D., Lyman, S., Qian, T., Lemasters, J. J., Rippe, R. A., Nitta, T., Js, K., & Behrns, K. E. (2007) · Biochimie · doi:10.1016/j.biochi.2007.09.001 · Cited by 50
Zhang, Y., Cui, Y., Wang, X., Shang, X., Qi, Z.-G., Xue, J., Zhao, X., Deng, M., & Xie, M.-L. (2015) · Cytokine · doi:10.1016/j.cyto.2015.05.031 · Cited by 49
Silbernagel, G., Hoffmann, M. M., Grammer, T. B., et al. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2011.02.008 · Cited by 48
Wakabayashi, Y., Fujita, H., Morita, I., Kawaguchi, H., & Murota, S. (1995) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(94)00202-p · Cited by 44
Losenkova, K., Zuccarini, M., Helenius, M., Jacquemet, G., Gerasimovskaya, E. V., Tallgrén, C., Jalkanen, S., & Yegutkin, G. G. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.03.001 · Cited by 44
Yang, C., Yang, S., Xu, W., Zhang, J., Fu, W., & Feng, C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177249 · Cited by 39
Reality of a Vaccine in the Prevention and Treatment of Atherosclerosis
García‐González, V., Delgado‐Coello, B., Pérez‐Torres, A., & Mas‐Oliva, J. (2015) · Archives of Medical Research · doi:10.1016/j.arcmed.2015.06.004 · Cited by 36
Self-citationSerum uric acid levels and cardiovascular disease: the Gordian knot
Martínez‐Quintana, E., Tugores, A., & Rodríguez‐González, F. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.11.39 · Cited by 35
Early Transcriptomic Response to LDL and oxLDL in Human Vascular Smooth Muscle Cells
Damián-Zamacona, S., Toledo-Ibelles, P., Ibarra-Abundis, M. Z., Uribe-Figueroa, L., Lemus, E. H., Macedo-Alcibia, K. P., Delgado‐Coello, B., Mas‐Oliva, J., & Reyes‐Grajeda, J. P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163924 · Cited by 31
Self-citationHuang, Q., Yu, J., Zhang, X., Liu, S., & Ge, Y. (2016) · Biomedical Reports · doi:10.3892/br.2016.698 · Cited by 28
Corona, A. E. J., Damián-Zamacona, S., Pérez‐Torres, A., Moreno, A., & Mas‐Oliva, J. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.03.001 · Cited by 26
Self-citationEmerging roles of calpain proteolytic systems in macrophage cholesterol handling
Miyazaki, T., & Miyazaki, A. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2528-7 · Cited by 22
MRI of atherosclerosis and fatty liver disease in cholesterol fed rabbits
Taylor, E. N., Huang, N., Bodde, J., Ellison, A., Killiany, R., Bachschmid, M. M., & Hamilton, J. A. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1587-3 · Cited by 17
Gutiérrez‐Vidal, R., Delgado‐Coello, B., Méndez-Acevedo, K. M., Calixto-Tlacomulco, S., Damián-Zamacona, S., & Mas‐Oliva, J. (2018) · Archives of Medical Research · doi:10.1016/j.arcmed.2019.01.007 · Cited by 17
Self-citationHigh mobility group box-1 release from H2O2-injured hepatocytes due to sirt1 functional inhibition
Ye, T., Lu, Y., Yan, X., Hu, X., & Wang, X.-L. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i36.5434 · Cited by 15
de Andrade, D. R., de Andrade, D. R., & dos Santos, S. A. (2009) · Arquivos de Gastroenterologia · doi:10.1590/s0004-28032009000400016 · Cited by 8
Mas‐Oliva, J., Delgado‐Coello, B., Méndez-Acevedo, K. M., Gutiérrez‐Vidal, R., & Calixto-Tlacomulco, S. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.06.177 · Cited by 4
Self-citationMas‐Oliva, J., Delgado‐Coello, B., & Méndez-Acevedo, K. M. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.07.020 · Cited by 2
Self-citation
Cited by
First-in-class MKK4 inhibitors enhance liver regeneration and prevent liver failure
Zwirner, S., Abu Rmilah, A. A., Klotz, S., Pfaffenroth, B., Kloevekorn, P., Moschopoulou, A. A., Schuette, S., Haag, M., Selig, R., Li, K., et al. (2024) · Cell · doi:10.1016/j.cell.2024.02.023 · Cited by 65
“Detected differences in metabolites between the HRX215-and vehicle-treated group were related to carnitines and hypoxanthines, offering a mechanistic explanation for the observed antisteatotic effects 35,36 (Figures S3A–S3C).”
Metadata
- Authors
- Toledo-Ibelles, P., Gutiérrez-Vidal, R., Calixto-Tlacomulco, S., Delgado-Coello, B., & Mas-Oliva, J.
- Affiliations
- Universidad Nacional Autónoma de México (MX)
- Venue
- Archives of Medical Research
- Publisher
- Elsevier BV
- Published
- 2021-10
- Volume
- 52
- Issue
- 7
- Pages
- 692-702
- ISSN
- 0066-6769 (ISSN-L)
- 0188-4409
- OpenAlex
- W3159156911
- Cited by
- 64
- References
- 49
- Citations by year
- 2026: 9 · 2025: 20 · 2024: 16 · 2023: 9 · 2022: 8 · 2021: 2
- FWCI
- 5.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Locations
- Archives of Medical Research (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Universidad Nacional Autónoma de México
- CONACYT
- Topics
- Health Sciences › Medicine › Nephrology › Gout, Hyperuricemia, Uric Acid
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- hypoxanthine, hyperuricemia, non-alcoholic fatty liver disease, purine metabolism, xanthine oxidoreductase, xanthine oxidase, xanthine dehydrogenase, oxidative stress, reactive oxygen species, high-fat diet, cholesterol, hepatocyte viability, HepG2 cells, rabbit model
- MeSH terms
- Animals, Hydrogen Peroxide, Liver, Male, Rabbits, Hypoxanthine, Hyperuricemia, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.